Pharmaceutical - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

26 to 50 of 417 results

US retinal specialists very receptive to pipeline agents for dry-AMD

US retinal specialists very receptive to pipeline agents for dry-AMD

05-06-2014

Surveyed US retinal specialists are highly willing to prescribe key emerging therapies for the treatment…

emixustatGlaxoSmithKlineGSK-933776Markets & MarketingOphthalmicsOtsukaPharmaceuticalResearchUSA

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

GSK begins to seek bids for its established products portfolio

GSK begins to seek bids for its established products portfolio

30-05-2014

UK pharma major GlaxoSmithKline has taken the first steps to divest some of its products in a bid to…

FinancialGlaxoSmithKlinePharmaceuticalUK

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

28-05-2014

UK pharma giant GlaxoSmithKline, already subject to allegations of bribery of doctors and hospitals in…

GlaxoSmithKlineLegalMarkets & MarketingPharmaceuticalUK

IQWIG finds added benefit in adult patients for VIIV Healthcare’s Tivicay

27-05-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTivicayViiV Healthcare

GSK commits to five-year vaccine price freeze for countries graduating from GAVI Alliance support

22-05-2014

UK pharma giant GlaxoSmithKline has said it will freeze the prices of its vaccines for a period of five…

GlaxoSmithKlineGlobalPharmaceuticalPricingVaccines

GSK and Genmab reveal disappointing Ph III data with ofatumumab + chemo in B-cell lymphoma

20-05-2014

UK Pharma major GlaxoSmithKline and Denmark’s Genmab revealed yesterday that the Phase III ORCHARRD…

GenmabGlaxoSmithKlineOfatumumab InjectionOncologyPharmaceuticalResearch

GlaxoSmithKline now accused of tax evasion in China

19-05-2014

The Legal Daily, the official newspaper of the Chinese Ministry of Justice, on Friday accused UK pharma…

ChinaFinancialGlaxoSmithKlineLegalPharmaceutical

GlaxoSmithKline divests rights to Treximet to Pernix for $250 million

15-05-2014

UK pharma giant GlaxoSmithKline will divest all of its rights to migraine drug Treximet (sumatriptan/naproxen…

GlaxoSmithKlineLicensingNeurologicalPernix TherapeuticsPharmaceuticalPozenTreximetUSA

Police close investigation on GlaxoSmithKline China's bribery case

Police close investigation on GlaxoSmithKline China's bribery case

14-05-2014

Chinese police have finished the investigation on the suspected bribery case of the local subsidiary…

ChinaGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Another disappointment for GlaxoSmithKline with darapladib

Another disappointment for GlaxoSmithKline with darapladib

13-05-2014

UK Pharma giant GlaxoSmithKline today announced disappointing headline results from its second Phase…

Cardio-vasculardarapladibGlaxoSmithKlinePharmaceuticalResearch

GlaxoSmithKline and Theravance’s Anoro Ellipta gains approval in EU

GlaxoSmithKline and Theravance’s Anoro Ellipta gains approval in EU

09-05-2014

The European Commission has granted marketing authorization for UK pharma giant GlaxoSmithKline and partner…

Anoro ElliptaEuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

US FDA approves GSK’s Incruse Ellipta for COPD

US FDA approves GSK’s Incruse Ellipta for COPD

01-05-2014

The US Food and Drug Administration has approved UK pharma major GlaxoSmithKline’s Incruse (umeclidinium)…

Chronic lower respiratory diseasesCOPDGlaxoSmithKlineIncruseIncruse ElliptaMajorMedicinePharmaceuticalPulmonologyRegulationRespiratory and PulmonaryUKUSA

Strong £ hits GlaxoSmithKline 1st-qtr 2014, as sales fall 10%

Strong £ hits GlaxoSmithKline 1st-qtr 2014, as sales fall 10%

30-04-2014

UK pharma giant GlaxoSmithKline posted a weak set of first-quarter 2014 financial results, with sales…

Andrew WittyChief executiveFinancialGlaxoSmithKlineHealthMedicinePharmaceutical

GSK gains EU marketing OK for Incruse for COPD; initiates tafenoquine Ph III program

GSK gains EU marketing OK for Incruse for COPD; initiates tafenoquine Ph III program

29-04-2014

UK pharma giant GlaxoSmithKline has received marketing authorization from the European Commission for…

EuropeGlaxoSmithKlineIncrusePharmaceuticalRespiratory and PulmonarytafenoquineTropical diseases

Positive CHMP opinion for GSK’s Mekinist in metastatic melanoma

27-04-2014

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

EuropeGlaxoSmithKlineMekinistOncologyPharmaceuticalRegulation

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

22-04-2014

In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

Canadian approval for GSK’s Incruse Ellipta as a treatment for COPD

17-04-2014

UK pharma giant GlaxoSmithKline says that Incruse Ellipta (umeclidinium) has received market authorization…

CanadaGlaxoSmithKlineIncruse ElliptaNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

GSK confirms further misconduct allegations, now in Jordan and Lebanon

17-04-2014

There has been recent publicity on cases of alleged misconduct by UK Pharma giant GlaxoSmithKline employees…

GlaxoSmithKlineJordanMarkets & MarketingPharmaceuticalRegulationRest of the World

FDA finally OKs GlaxoSmithKline’s Tanzeum to treat type 2 diabetes

FDA finally OKs GlaxoSmithKline’s Tanzeum to treat type 2 diabetes

16-04-2014

UK pharma giant GlaxoSmithKline yesterday received the much anticipated approval from the US Food and…

albiglutideDiabetesGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationTanzeumUSA

GSK faces bribery allegations in Poland

GSK faces bribery allegations in Poland

14-04-2014

UK pharma major GlaxoSmithKline is facing allegations of bribing doctors in Poland, according to the…

BBCGlaxoSmithKlineGSK regional managerLegalMajorMedicinePharmaceuticalPolandPulmonologyRespiratory and PulmonarySeretideUK

26 to 50 of 417 results

Back to top